Hexo Corp (NYSE: HEXO) Gets a Buy Rating From MKM Partners

Browse By

MKM Partners analyst William Kirk reiterated a Buy rating on HEXO on December 6 and set a price target of C$6.00. The company’s shares closed last Monday at $2.09, close to its 52-week low of $1.56.

About HEXO Corp

HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. Through its hub and spoke business strategy, HEXO Corp is partnering with Fortune 500 companies, bringing its brand value, cannabinoid isolation technology, licensed infrastructure and regulatory expertise to established companies, leveraging their distribution networks and capacity. As one of the largest licensed cannabis companies in Canada, HEXO Corp operates facilities in Ontario and Quebec. The Company is also expanding internationally and has a foothold in Greece to establish a Eurozone processing, production and distribution centre. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. For more information please visit hexocorp.com.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.